Regulatory and clinical research organization, dedicated to supporting companies in the in vitro diagnostic and precision medicine sector.
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
259
NCT02203604
High-Dose Aldesleukin and Ipilimumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery
Phase: Phase 2
Role: Lead Sponsor
Start: Nov 26, 2014
Completion: Jan 27, 2020
NCT06778564
Stratification and Treatment in Early Psychosis Study - ENHANCE
Phase: Phase 3
Role: Collaborator
Start: Apr 30, 2025
Completion: Dec 31, 2028
Loading map...